Citadel Advisors »

Checkpoint Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Checkpoint Therapeutics (CKPT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Checkpoint Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Checkpoint Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Checkpoint Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $198k 87k 2.29
2023-09-30 $45k 26k 1.70
2023-06-30 $90k 36k 2.47
2023-03-31 $108k 48k 2.25
2022-12-31 $161k 32k 5.11

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Checkpoint Therapeutics

Vanguard Group
National Asset Management
Advisor Group Holdings
D. E. Shaw & Co
Pvg Asset Management
Citadel Advisors
Legacy Wealth Asset Management
Royal Bank of Canada
Park Avenue Securities
Wealth Enhancement Advisory Services
Jane Street
Lindbrook Capital
Rsm Us Wealth Management
Wells Fargo & Company
Emfo

View all funds holding Checkpoint Therapeutics